Homeβ€ΊSearchβ€ΊCytotherapy

Cytotherapy

Elsevier B.V. Β· United States Β· Est. 1914

ISSN1477-2566
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

πŸ“Š Standing in its field
Where this journal ranks among others in the same subject area.
Q1
SJR Β· Scopus
Top 25% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
1.249
H-Indexi
125
SNIPi
0.727
Total Worksi
9,342
Total Citationsi
121,517
2yr Mean Citednessi
1.03
Open Impact Factor alternative
Retractions
3
Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Cytotherapy publishes novel and innovative results from scientific and clinical studies in the fields of cell, gene, and extracellular vesicle therapy. The journal covers translational research, stem cells, cellular therapies, vaccines, gene therapy, immunotherapy, tissue engineering, and blood and bone marrow. It is dedicated to providing readers with the latest advancements in the rapidly evolving field of human cell therapy, particularly in relation to cancer, immune diseases, genetic disorders, tissue repair, and regenerative medicine.

AI-compiled from public web sources Β· verify on publisher page β†’

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published1914
FrequencyEight No. A Year, 2007-
StatusActive (last: 2026)
Total Publications9,342
Publisher OrgElsevier BV
Visit Journal Website

Submission Info

Peer Reviewβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/11 Β· 55%
βœ…
Do you know the journal / publisher?
Elsevier B.V.
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1477-2566
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

A twelfth criterion β€” whether APC fees are clearly disclosed β€” is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
445
4k
2019
661
3.7k
2020
656
2.4k
2021
663
2k
2022
783
1.8k
2023
780
1.7k
2024
755
689
2025
775
39
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Genetics (clinical)Q1
OncologyQ1
TransplantationQ1
Cancer ResearchQ2
Cell BiologyQ2
ImmunologyQ2
Immunology and AllergyQ2

Subject Classification

Web of Science Categories

Biotechnology & Applied MicrobiologyCell & Tissue EngineeringCell BiologyHematologyMedicine, Research & Experimental

Scopus Categories

ImmunologyCancer ResearchTransplantationImmunology and AllergyOncologyGenetics (clinical)Cell Biology

Research Topics (OpenAlex)

Mesenchymal stem cell researchCAR-T cell therapy researchHematopoietic Stem Cell TransplantationTissue Engineering and Regenerative MedicinePluripotent Stem Cells ResearchImmune Cell Function and InteractionDiverse Scientific and Economic StudiesBiomedical Ethics and RegulationImmunotherapy and Immune ResponsesViral Infectious Diseases and Gene Expression in Insects

Frequently asked questions about Cytotherapy

Is Cytotherapy a predatory journal?

PubScope has no integrity flags on record for Cytotherapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Cytotherapy?

Cytotherapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.03.

Is Cytotherapy indexed in Scopus and Web of Science?

Cytotherapy is indexed in Web of Science, Scopus.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref